Free Trial

Obesity Drug Boom, Split Make This Stock a Heavy Bargain

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Novo Nordisk A/S (NVO)
4.7751 of 5 stars
$44.91-0.1%3.90%10.54Hold$65.56
Eli Lilly and Company (LLY)
4.8237 of 5 stars
$1,066.590.1%0.65%37.89Moderate Buy$1,222.63
Mondelez International (MDLZ)
4.3642 of 5 stars
$61.76flat3.24%30.73Moderate Buy$67.05
Nestle (NSRGY)
1.3656 of 5 stars
$100.55flat2.54%N/AHoldN/A
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines